A4SV44 AF NFT

Glutamyl-tRNA reductase

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeiagylcg7a75y4on2eelu3kww5yh2jtizpkjhr3g44tp5cslu7twre/metadata.json
IPFS of structure file: 
bafybeib7as57u7ttufj3o2tn5xgkmmhyz37pvhg7jvaghs2adzyhmohdlu/AF-A4SV44-F1-model_v2.pdb
First NFT owner address (eip-55): 
0xf4ED13986579E8e227b3ED6c02276c648754EC27
First NFT owner address (bech32): 
genesis17nk38xr9085wyfana4kqyfmvvjr4fmp80usw7n
Current NFT ID #166788 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
166788
Accession (UniProt):
A4SV44
Name::
Glutamyl-tRNA reductase
Experimental Method:
Predicted structure
Sequence source:
Polynucleobacter asymbioticus (strain DSM 18221 / CIP 109841 / QLW-P1DMWA-1)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT A4SV44 research and analysis (ICN3D with VR)

FASTA sequences

>sp|A4SV44|HEM1_POLAQ Glutamyl-tRNA reductase OS=Polynucleobacter asymbioticus (strain DSM 18221 / CIP 109841 / QLW-P1DMWA-1) OX=312153 GN=hemA PE=3 SV=1 MKLLTLGINHHTAPVAIREKVAFDPEFLQEALHDLRQHLLGANQSGLPEATILSTCNRTEVYCAANDANAANILHEATFDWLAKTQQLAPSSLQPHIYSLPQSDAVRHAFRVACGLDSMVIGETQILGQMKDAVRTANDAGVLGTYLNQLFQKTFAVAKEVRGSTEIGTHSISMAAASVRLSERIFEKISEQKILFIGAGDMITLCATHFVARKPKNVAIANRTIERGQELADSISAQDVQAESLKLSELPGRLHEFDIIVSSTASSLPIIGLGMVESALKQRRHKPMVMIDLAVPRDFEPEIARLDDVYLYTVDDLGVMIQTGTNLRQAAVSQAEAIIEDRVGNFMHWMQGRNAVPVIQDIQQQGERLRQLELERAMKRLMRGDDPQEVLNAMAQGLTNKFLHGSLHALQHSNGAERDALIKLLPKLFASHSKPEDH